50-year-old chemotherapy drug doxorubicin linked to heart damage, researchers identify overactive immune cells causing cardiac damage.
50-year-old chemotherapy drug, doxorubicin, linked to heart damage. Researchers from Tufts University School of Medicine and Tufts Graduate School of Biomedical Sciences have isolated immune cells that become overactive while patients take doxorubicin, contributing to cardiac damage. Findings were published in Nature Cardiovascular Research, revealing a potential pathway for controlling complications.
July 17, 2024
3 Articles